Expresión de la ciclooxigenasa-2 en los carcinomas mamarios caninos primarios metastásicos y no metastásicos

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorUniversidad Federal de Paraná
dc.contributorUniversidad Estadual del Norte de Paraná
dc.date.accessioned2022-04-29T07:13:47Z
dc.date.accessioned2022-12-20T02:27:40Z
dc.date.available2022-04-29T07:13:47Z
dc.date.available2022-12-20T02:27:40Z
dc.date.created2022-04-29T07:13:47Z
dc.date.issued2013-01-01
dc.identifierArchivos de Medicina Veterinaria, v. 45, n. 3, p. 311-316, 2013.
dc.identifier0717-6201
dc.identifier0301-732X
dc.identifierhttp://hdl.handle.net/11449/227529
dc.identifier10.4067/S0301-732X2013000300012
dc.identifier2-s2.0-84893272184
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5407664
dc.description.abstractThe aim of this study was to detect the expression of ciclooxigenase-2 (COX-2) in metastatic primary carcinoma and non metastatic carcinoma, taking into consideration the relation between COX-2 and the progression of cancer. Evaluation of the COX-2 expression was achieved by immunohistochemistry analysis, using the primary polyclonal antibody anti-PGHS-2, clone PG 27, (Oxford Biomedical Research). The number of marked cells by the COX-2 antibody was higher (P > 0.001) in the metastatic primary carcinoma (81.25%) than non-metastatic (60.3%). There was a positive correlation between the number of labeled cells.
dc.languagespa
dc.relationArchivos de Medicina Veterinaria
dc.sourceScopus
dc.subjectCancer
dc.subjectCiclooxigenase-2
dc.subjectDogs
dc.subjectMammary neoplasm
dc.titleExpresión de la ciclooxigenasa-2 en los carcinomas mamarios caninos primarios metastásicos y no metastásicos
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución